REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2014

Nov 20, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2014-11-18

Reporting Person: STAHL NEIL (SVP Research and Development S)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-18	Common Stock	M	16757.0	$115.29	Acquired	30284	Direct
2014-11-18	Common Stock	F	4747.0	$406.93	Disposed	25537	Direct
2014-11-18	Common Stock	F	6703.0	$406.93	Disposed	18834	Direct
2014-11-18	Common Stock	G	250.0	$0.0	Disposed	18584	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-18	Non-Qualified Stock Option (right to buy)	$115.29	M	16757.0	Disposed	2016-12-18	Common Stock (16757)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20000	Indirect
Common Stock	10864	Indirect
Common Stock	5568	Indirect